OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Dermatological Treatment is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial	82
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis	71
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	67
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	55
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	46
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	44
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	38
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	38
A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol	34
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	31
Topical delgocitinib for the treatment of chronic hand eczema	28
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	28
Lessons from a decentralized trial in atopic dermatitis: promises and perils	26
Skin type classifications: does the perfect assessment exist?	26
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	26
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	25
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	24
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits	24
Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study	22
A pediatric case of dupilumab-induced pustular psoriasis	21
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	21
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	21
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study	21